People · Operator
Named in public records as an officer, director or promoter · active 2009–2012 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Wispry Inc | — | Other Technology | Series B | $61.5M | $243.6M | 2009 |
| Quantalife Inc | — | Biotechnology | Series B | $36.2M | $141.2M | 2009 |
| Luminus Devices Inc | — | Other Technology | Series B | $35.8M | $213.2M | 2012 |
Paul A. Conley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul A. Conley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| PAUL CONLEY | 1 | 17 |
| Jeffrey Samberg | 1 | 14 |
| John Levy | 1 | 10 |
| Oded Weiss | 1 | 4 |
| Michael J. Moniz | 1 | 3 |
| Keith Ward | 1 | 3 |
| Bart Schachter | 1 | 2 |
| Mark Czepiel | 1 | 2 |
| LEONARD G. BARBIERI | 1 | 2 |
| Harry Laswell | 1 | 2 |
| Christopher T Blisard | 1 | 2 |
| Bill W. Colston | 1 | 2 |
| Mark Becker | 1 | 2 |
| Russell Garcia | 1 | 2 |
| Benjamin J. Hindson | 1 | 1 |
| Richard A. Ding | 1 | 1 |
| TED HOBART | 1 | 1 |
| RUSSELL JOHNSEN | 1 | 1 |
| Paul K. Kidman | 1 | 1 |
| Gerry McClure | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.